A five-year, £5 million initiative has just been launched to investigate the feasibility of using new blood tests in the diagnosis of Alzheimer's disease. Alzheimer's Research UK and the Alzheimer's Society are working with ...
Nov 20, 2023
0
0
For the first time, a research team in Korea has discovered there is a significant relationship between depression and the taurine concentration in the hippocampus, an area of the brain responsible for memory and learning ...
Nov 14, 2023
0
2
High-grade gliomas are cancerous tumors that spread quickly in the brain or spinal cord. In a new study led by Mayo Clinic, researchers found invasive brain tumor margins of high-grade glioma (HGG) contain biologically distinct ...
Nov 13, 2023
0
11
When researchers in Dalhousie's NeuroCognitive Imaging Lab (NCIL) designed a huge, two-year reading comprehension study involving approximately 100 children from grades two and three, they faced a major challenge. They had ...
Nov 10, 2023
0
0
Giving children a virtual/augmented (mixed) reality play set to use ahead of an MRI (magnetic resonance imaging) scan seems to ease both their and their parents' anxieties about this procedure, suggest preliminary findings ...
Nov 7, 2023
0
4
A study by researchers at EPFL shows why only a subset of individuals exposed to trauma develop posttraumatic stress disorder (PTSD). The research, centered on the body's stress hormone response, could pave the way for more ...
Nov 7, 2023
0
16
Researchers have used methods from high-performance computing to significantly reduce the time it takes to reconstruct images acquired through four-dimensional magnetic resonance imaging (4D-MRI), a leading-edge, high-quality ...
Oct 30, 2023
0
0
Artificial intelligence can help health care systems under pressure allocate limited resources, but also lead to more unequal access. This is demonstrated by a research collaboration between the University of Copenhagen, ...
Oct 26, 2023
0
0
A variety of risks can make it more likely that someone develops Alzheimer's disease or other dementias.
Oct 26, 2023
0
0
An experimental version of Eisai Co's Alzheimer's drug that might be given in patients' homes exceeded the power of Leqembi, its approved infused formulation, in an early study that could pave the way to bolstering uptake.
Oct 26, 2023
0
1
